Please login to the form below

Not currently logged in
Email:
Password:

AstraZeneca to cut 8,000 jobs

Anglo-Swedish pharmaceutical giant, AstraZeneca is to cut 8,000 jobs worldwide by 2014

Anglo-Swedish pharmaceutical giant, AstraZeneca (AZ) has announced it is to cut 8,000 jobs worldwide by 2014.

AZ, which employs 11,000 people in the UK, including offices in London, Macclesfield, Cheshire, Luton and Bristol, has yet to say how the job cuts will affect the UK.

The cuts come on top of 12,600 job losses since 2007 as the firm continues to further its 'productivity programmes' which have already saved $1.6bn. AZ has predicted a further $1.8bn to be saved over the next four years with this latest announcement.

The losses will come in the firm's sales and marketing, business infrastructure, research and development, and supply chain operations, as AZ looks to focus on its more profitable drugs and treatment departments.

There was also a warning that some research and development sites could be closed.

The news comes as AZ announced a "strong financial performance in 2009" which saw the firm's annual revenues increase by seven per cent, as well as the elimination of its $7,174m net debt.

28th January 2010

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
AMICULUM Limited

AMICULUM® is an independent global healthcare communications, consulting and learning business with a global team of >220 healthcare communications professionals,...

Latest intelligence

AstraZeneca’s oncology renaissance
Susan Galbraith played a key role in restoring AstraZeneca’s place in cancer drug development – she talks about the future of oncology and why there’s more to be done to...
Navigating the antibiotic resistance crisis
Blue Latitude Health speaks to Tara DeBoer, PhD, Postdoctoral Researcher and CEO of BioAmp Diagnostics to explore the antimicrobial resistance crisis, and learn how a simple tool could support physicians...
Combined immunotherapies – potential and pitfalls
‘Combining therapeutic compounds is the first logical step towards better results, namely higher rates of patients responding to treatment, with deeper and more sustained responses’...

Infographics